Copper Peptides + Vitamin C: Do They Cancel Out?

Ask whether you can use copper peptides with vitamin C and the internet hands you two confident answers, both wrong. One camp says the pair cancels out, as though the two ingredients meet and neutralise each other into nothing. The other calls the warning a myth invented to sell more bottles. The chemistry is more specific than either: copper peptides and L-ascorbic acid do not cancel each other, they degrade each other, and the degradation runs in both directions for two entirely different reasons. What follows is formulation chemistry rather than a routine, educational and not medical or cosmetic advice.

Do copper peptides and vitamin C cancel each other out?

"Cancel out" is a biology phrase borrowed for a chemistry problem. It implies both ingredients survive intact and simply stop working, as though the copper peptide switched vitamin C off the way one drug blocks another at a receptor. That is not what the literature describes. What it describes is mutual chemical degradation: the conditions that keep L-ascorbic acid intact and able to enter skin are the same conditions that pull a copper-peptide complex away from the coordination chemistry defining it, and copper is among the more efficient catalysts of ascorbate oxidation known. Neither ingredient neutralises the other's activity; each shortens the other's chemical life. That distinction matters: it makes the outcome a question of formulation, not of some inherent incompatibility between the molecules.^{[1, 3]}

Why L-ascorbic acid has to be formulated acidic

L-ascorbic acid is the form of vitamin C with the deepest topical research record, and it arrives with a hard constraint. In percutaneous absorption work on pig skin, Pinnell and colleagues reported that L-ascorbic acid must be formulated at a pH below 3.5 to enter skin at all, with an optimal concentration of 20%. Acidity is not optional for a second reason either: ascorbate oxidises readily in water, and the rate climbs as pH climbs, because the more reactive dianion becomes more abundant. A review of ascorbate stability describes that rate as driven up by metal ions such as copper and iron and by base, meaning high pH, which is why an acidic environment is preferred whenever the goal is keeping ascorbate intact. A working serum is therefore acidic twice over: acidic enough to cross skin, and acidic enough to survive on a shelf.^{[1, 3]}

What an acidic formula does to the copper-peptide complex

GHK-Cu is not a molecule in the way a single covalent compound is. It is a coordination complex: the tripeptide glycyl-L-histidyl-L-lysine holding a copper(II) ion through donor atoms whose availability depends on pH. Lau and Sarkar characterised that system potentiometrically and by visible-absorption spectrophotometry across the pH range 3.5 to 10.6, reporting multiple coexisting species rather than one. The consequence is the part skincare writing usually skips. Coordination relies on nitrogen donors, including the deprotonated amide nitrogen of the glycine-histidine bond, which are only available while unprotonated. Push the pH low enough and those donors reclaim their protons, the coordination weakens, and the copper is no longer held the way the research describes. Nothing is annihilated; the equilibrium simply moves.^{[2, 10]}

Where the published stability data actually stops

So where does that equilibrium sit at vitamin C pH? The published stability work does not say. A preformulation study of GHK-Cu found the compound susceptible to hydrolytic cleavage under basic and oxidative stress and, to a lesser extent, acidic stress, and reported it stable in water and in buffers from pH 4.5 to 7.4 for at least two weeks at 60 degrees Celsius. That envelope stops at 4.5, while a functional L-ascorbic acid serum sits below 3.5. The most-cited stability data on the copper peptide does not cover the pH a vitamin C serum actually runs at. Unsatisfying, but more accurate than either "they cancel" or "it's a myth".^{[8, 1]}

What copper does to vitamin C

The other direction is far better characterised, and not specific to peptides: copper is a textbook catalyst of ascorbate oxidation. A kinetic review and model of ascorbate oxidation by iron, copper and reactive oxygen species reported that for both iron(III) and copper(II) the catalytic pathway dominates the reactive-oxygen-species pathway by orders of magnitude, that micromolar concentrations of these metals are a larger sink for ascorbic acid than reactive oxygen species themselves, and that the metal-catalysed reaction yields hydrogen peroxide. The same work noted that copper(II) catalyses ascorbic acid oxidation more efficiently at neutral pH than at acidic pH, which is the formulation argument in one line: the acid a vitamin C serum needs is partly what shields it from the copper. Nor is the reaction silent: copper-catalysed aerobic oxidation of ascorbate can lead to superoxide, hydrogen peroxide and the hydroxyl radical, working against the antioxidant reason the serum was chosen.^{[4, 3, 7]}

Bound copper is not free copper

Here the simple story breaks down. A copper ion loose in water is an excellent oxidation catalyst; a copper ion held inside a peptide is a different chemical object whose behaviour depends on how it is coordinated. Work on copper(II) bound to histidine-containing oligopeptides found catalytic behaviour tracking the coordination mode: copper held within an imidazole cluster enhanced ascorbic acid autoxidation roughly twofold relative to aqueous copper(II), while copper bound tightly at the amino-terminal motif suppressed the reaction instead. For GHK specifically, the evidence leans quiet. A structural and electrochemical comparison of Cu(II)GHK and Cu(II)DAHK reported both complexes inert under moderate redox potentials, with Cu(II)GHK reducible to Cu(I) only at a strongly negative potential, and the copper ion released once that happens. A later study notes that earlier work showed Cu(II)GHK inert versus physiological levels of ascorbate, which is why those authors turned to glutathione, a stronger reductant. The widely cited GHK review echoes this, describing copper's redox activity as silenced while bound to the tripeptide.^{[5, 6, 9, 10]}

Why the two halves of the problem are not independent

Read together, that is a real qualification on the scare story: an intact GHK-Cu complex is not obviously a fast destroyer of ascorbate, and pages describing copper peptides as instantly wrecking vitamin C overstate what the redox data shows. The load-bearing word there is intact. The redox-silencing argument assumes the complex is still assembled, and putting it in a formula acidic enough for L-ascorbic acid to work is precisely what puts that assumption in question. Free copper is the pro-oxidant form, and reduction of the complex has itself been reported to release the copper ion. So the pH conflict is what opens the door to the oxidation conflict; the two halves are not independent problems.^{[6, 10]}

What this chemistry can and cannot tell you

Everything above is benchtop chemistry and formulation science, a limit worth stating plainly rather than burying. There is no controlled human study we could find that tests a finished GHK-Cu cosmetic against a finished L-ascorbic acid serum on skin and measures what happens to either. The pH figures are solid; the redox chemistry is well characterised in water; the leap from either to what happens on a face over twelve weeks is not one the literature has made. What the chemistry does support, modestly: the two want opposite conditions, they have a documented mechanism for shortening each other's shelf life, and the size of that effect turns on formulation details a shopper cannot read off a label.

Why vitamin C derivatives change the question

Most of the tension above belongs to L-ascorbic acid specifically, because it is the form demanding a very low pH. Derivatives such as magnesium ascorbyl phosphate and ascorbyl-6-palmitate are formulated at gentler pH values, removing the acid-versus-complex half of the conflict outright. The honest catch sits in the same Pinnell dataset: those derivatives, tested on pig skin alongside L-ascorbic acid, did not raise skin levels of L-ascorbic acid. The compatibility gain is real, and the thing being made compatible is a form with a markedly weaker delivery record. Pages recommending derivatives as the easy answer rarely say so.^[1]

Risks, unknowns, and the supply question

Two risks deserve naming, neither dramatic. First, the pro-oxidant one: where a copper species is freed in an environment rich in ascorbate and oxygen, the copper-ascorbate couple is a documented generator of hydrogen peroxide and hydroxyl radicals. Whether that ever reaches a meaningful level on human skin from a cosmetic is not established, so it is a theoretical risk with real underlying chemistry rather than a demonstrated one. Second, tolerability: strongly acidic formulas are more likely to sting or redden sensitive skin, and copper is a reactive metal a minority of people react to. Reported user experiences are anecdotes, not evidence, and our guide at /learn/copper-peptides-ruined-my-skin separates irritation, a claimed purge and a true allergy, three things routinely reported as one. The third issue sits upstream of both: research-grade copper peptide is a raw laboratory material, not a cosmetic, carrying no formulation, no pH buffering and no stabiliser system, and it is not approved by the FDA for human use. Independent impurity profiling of falsified peptide products has found purity varying widely and toxic elemental impurities including arsenic and lead.^{[7, 4, 11]}

The short answer, stated carefully

In one sentence: copper peptides and vitamin C do not cancel each other out, but L-ascorbic acid needs a pH low enough to sit outside the range where copper-peptide stability has actually been demonstrated, and free copper is among the more efficient catalysts of ascorbate oxidation. That makes it a formulation problem rather than a biological one, and how much it matters depends on a specific product's chemistry rather than on a rule that holds for every bottle. Anyone offering a confident answer in either direction has gone past the evidence. For what the cosmetic research on the molecule itself shows, see our guide at /learn/copper-peptides-for-skin. If the reason you are reading this is a reaction you are already having, /learn/copper-peptides-ruined-my-skin is the more useful page.

References & sources

1. Pinnell SR, Yang H, Omar M, et al. Topical L-ascorbic acid: percutaneous absorption studies. Dermatol Surg (2001);27(2):137-142.
2. Lau SJ, Sarkar B. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma. Biochem J (1981);199(3):649-656.
3. Wagner BA, Buettner GR. Stability of aqueous solutions of ascorbate for basic research and for intravenous administration. Adv Redox Res (2023);9:100077.
4. Shen J, Griffiths PT, Campbell SJ, et al. Ascorbate oxidation by iron, copper and reactive oxygen species: review, model development, and derivation of key rate constants. Sci Rep (2021);11:7417.
5. Ueda J, Hanaki A, Hatano K, Nakajima T. Autoxidation of ascorbic acid catalyzed by the copper(II) bound to L-histidine oligopeptides: relationship between catalytic activity and coordination mode. Chem Pharm Bull (2000);48(7):908-913.
6. Hureau C, Eury H, Guillot R, et al. X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties. Chemistry (2011);17(36):10151-10160.
7. Falcone E, Stellato F, Vileno B, et al. Revisiting the pro-oxidant activity of copper: interplay of ascorbate, cysteine, and glutathione. Metallomics (2023);15(7):mfad040.
8. Badenhorst T, Svirskis D, Wu Z. Physicochemical characterization of native glycyl-L-histidyl-L-lysine tripeptide for wound healing: a preformulation study for dermal delivery. Pharm Dev Technol (2016);21(2):152-160.
9. Ufnalska I, Drew SC, Zhukov I, et al. Intermediate Cu(II)-thiolate species in the reduction of Cu(II)GHK by glutathione: a handy chelate for biological Cu(II) reduction. Inorg Chem (2021);60(23):18048-18057.
10. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int (2015);2015:648108.
11. Janvier S, Cheyns K, Canfyn M, et al. Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market. Talanta (2018);188:795-807.